Patent classifications
C07C2603/92
Process for the high-yield preparation of P-(R)calix[9-20]arenes
A process for the high-yield preparation of p-(R)calix[9-20]arenes.
COLORED FUNCTIONALIZED [2,2] PARACYCLOPHANE AND COLORED CHEMICAL FILM
Disclosed herein are a colored functionalized paracyclophane represented by Formula (I) and a colored chemical film represented by Formula (II):
##STR00001## wherein A, o, and p in Formula (I) and Formula (II) are as defined herein. The colored chemical film may be formed from the colored functionalized [2,2]paracyclophane by chemical vapor deposition.
Materials for organic electroluminescent devices
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds. ##STR00001##
CATIONIC PILLARARENE COMPOUNDS AND COMPOSITIONS
Cationic pillar[n]arenes, e.g., positively charged poly-ammonium, poly-phosphonium and poly-imidazolium pillar[5-6]arene derivatives are capable of inhibiting or preventing biofilm formation, and facilitating existing biofilm decomposition. A composition for inhibiting or disrupting biofilm, e.g., bacterial or fungal biofilm, formation, or reducing biofilm, can include a pharmaceutically acceptable carrier, and a cationic pillar[n]ene.
Cationic pillararenes and uses thereof
The present invention provides cationic pillar[n]arenes, e.g., positively charged poly-ammonium, poly-phosphonium and poly-imidazolium pillar[5-6]arene derivatives, capable of inhibiting or preventing biofilm formation, and facilitating existing biofilm decomposition; as well as compositions thereof and methods of use.
METHOD FOR INHIBITING OR DISRUPTING BIOFILM FORMATION, OR REDUCING BIOFILM
Cationic pillar[n]arenes, e.g., positively charged poly-ammonium, poly-phosphonium and poly-imidazolium pillar[5-6]arene derivatives are capable of inhibiting or preventing biofilm formation, and facilitating existing biofilm decomposition. A composition for inhibiting or disrupting biofilm, e.g., bacterial or fungal biofilm, formation, or reducing biofilm, can include a pharmaceutically acceptable carrier, and a cationic pillar[n]ene.
CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF
A catalyst system for olefin polymerization contains a main catalyst and a cocatalyst. The cocatalyst contains a twelve-membered ring compound represented by formula (M). The catalyst system is suitable for preparing polypropylene products having high stereoregularity and low ash, and can regulate the melt index of the products within a wide range by adjusting the amount of hydrogenation. It is also suitable for copolymerization systems to improve the copolymerization yield.
##STR00001##
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
- Anna Rita Blanco ,
- Maria Luisa Bondi' ,
- Gennara Cavallaro ,
- Grazia Maria Letizia Consoli ,
- Emanuela Fabiola Craparo ,
- Gaetano Giammona ,
- Mariano Licciardi ,
- Giovanna Pitarresi ,
- Giuseppe Granata ,
- Patrizia Saladino ,
- Clara La Marco ,
- Irene Ceidda ,
- Salvatore Papasergi ,
- Patrizia Guarneri ,
- Salvatore Cuzzocrea ,
- Emanuela Esposito ,
- Santa VIOLA
Formulations are described, containing silibinin or other active ingredients incorporated in lipid nanoparticle systems of the SLN and NLC type, and based on calixarenes, possibly mucoadhesive, or in micellar and nanoparticle systems based on amphiphilic inulin copolymers for use in the treatment of neurodegenerative ocular diseases. The versatility of the calixarene compound is also described, capable of charging and releasing active ingredients characterized by low water solubility, easy chemical and enzymatic degradation, low bioavailability, either of natural origin or not, to be used in the treatment of ocular diseases.
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
- Anna Rita Blanco ,
- Maria Luisa Bondi′ ,
- Gennara Cavallaro ,
- Grazia Maria Letizia Consoli ,
- Emanuela Fabiola Craparo ,
- Gaetano Giammona ,
- Mariano Licciardi ,
- Giovanna Pitarresi ,
- Guiseppe Granata ,
- Patrizia Saladino ,
- Clara La Marca ,
- Irene Deidda ,
- Salvatore Papasergi ,
- Patrizia Guarneri ,
- Salvatore Cuzzocrea ,
- Emanuela Esposito ,
- Santa Viola
Formulations are described, containing silibinin or other active ingredients incorporated in lipid nanoparticle systems of the SLN and NLC type, and based on calixarenes, possibly mucoadhesive, or in micellar and nanoparticle systems based on amphiphilic inulin copolymers for use in the treatment of neurodegenerative ocular diseases. The versatility of the calixarene compound is also described, capable of charging and releasing active ingredients characterized by low water solubility, easy chemical and enzymatic degradation, low bioavailability, either of natural origin or not, to be used in the treatment of ocular diseases.
Rechargeable Aluminum Organic Batteries
Disclosed herein are rechargeable aluminum organic batteries and active materials used therein. The cathodic materials used herein comprise a macrocycle comprising a substituted or unsubstituted phenanthrenequinone unit and a graphite flake.